Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · Real-Time Price · USD
0.6851
+0.0140 (2.09%)
At close: Dec 19, 2025, 4:00 PM EST
0.6900
+0.0049 (0.72%)
After-hours: Dec 19, 2025, 7:24 PM EST
Salarius Pharmaceuticals Market Cap
Salarius Pharmaceuticals has a market cap or net worth of $4.02 million as of December 19, 2025. Its market cap has increased by 92.19% in one year.
Market Cap
4.02M
Enterprise Value
-793.50K
1-Year Change
92.19%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since July 22, 2019, Salarius Pharmaceuticals's market cap has decreased from $44.21M to $4.02M, a decrease of -90.92%. That is a compound annual growth rate of -31.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 4.02M | 51.46% |
| Dec 31, 2024 | 2.65M | 3.58% |
| Dec 29, 2023 | 2.56M | -26.56% |
| Dec 30, 2022 | 3.49M | -84.44% |
| Dec 31, 2021 | 22.40M | 3.42% |
| Dec 31, 2020 | 21.66M | 41.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |